Pontine gliomas a 10-year population-based study: a report from The Canadian Paediatric Brain Tumour Consortium (CPBTC)
Adriana Fonseca, Éric Bouffet(Hospital for Sick Children), Katrin Scheinemann(University of Lucerne), Magimairajan Vanan(CancerCare Manitoba), Lucie Lafay‐Cousin(Women & Children's Hospital of Buffalo), Lynette Bowes(Janeway Children's Health and Rehabilitation Centre), Shayna Zelcer(London Health Sciences Centre), Adam Fleming(Montreal Children's Hospital), Donna L. Johnston(Children's Hospital of Eastern Ontario), David D. Eisenstat(Royal Children's Hospital), Chris Mpofu(Saskatchewan Cancer Agency), Cynthia Hawkins(Hospital for Sick Children), Nada Jabado(McGill University), Valérie Larouche, Bruce Crooks(Izaak Walton Killam Health Centre), Sébastien Perreault(Centre Hospitalier Universitaire Sainte-Justine), Mariana Silva(Queen's University), Samina Afzal, Juliette Hukin(BC Children's Hospital), Beverly Wilson(University of Alberta), Ute Bartels(Hospital for Sick Children)
Cited by 13
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795